The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: Rationale, Design, Results, Clinical Implications and Lessons for Future Trials

By Wilkoff B.L.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 468-472

Springer Publishing Company

Access to resources Recommend Favorite

Lessons from the stroke prevention in atrial fibrillation trials

By Hart R.G.   Halperin J.L.   Pearce L.A.   for the Stroke Prevention in Atrial Fibrillation Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 67-67

Elsevier

Access to resources Recommend Favorite

What is the best endpoint for ablating atrial flutter?

By Krummen D.   Narayan S.  

Journal of Interventional Cardiac Electrophysiology, Vol. 15, Iss. 2, 2006-03 ,pp. : 103-105

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials of Prophylactic Implantable Defibrillator Therapy in Patients with Nonischemic Cardiomyopathy: What have We Learned and What can We Expect from Future Trials?

By Grimm W.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 463-467

Springer Publishing Company

Access to resources Recommend Favorite

Implantable Dual-Chamber Defibrillator for the Selective Treatment of Spontaneous Atrial and Ventricular Arrhythmias: Arrhythmia Incidence and Device Performance

By Schuchert Andreas   Boriani Giuseppe   Wollmann Christian   Biffi Mauro   Kühl Martin   Sperzel Johannes   Stiller Sascha   Gasparini Gianni   Böcker Dirk  

Journal of Interventional Cardiac Electrophysiology, Vol. 12, Iss. 2, 2005-03 ,pp. : 149-156

Springer Publishing Company

Access to resources Recommend Favorite